Short Interest in ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Grows By 94.3%

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 68,200 shares, an increase of 94.3% from the May 31st total of 35,100 shares. Currently, 1.9% of the shares of the company are short sold. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

ThermoGenesis Price Performance

NASDAQ:THMO remained flat at $0.22 during mid-day trading on Friday. 12,775 shares of the company traded hands, compared to its average volume of 221,557. The stock’s 50 day moving average is $0.54 and its 200 day moving average is $0.64. ThermoGenesis has a 12-month low of $0.20 and a 12-month high of $1.82.

ThermoGenesis (NASDAQ:THMO) last issued its quarterly earnings data on Monday, April 15th. The company reported ($2.33) earnings per share for the quarter. ThermoGenesis had a negative net margin of 153.43% and a negative return on equity of 4,838.39%. The firm had revenue of $2.41 million during the quarter. As a group, equities analysts anticipate that ThermoGenesis will post 0.08 EPS for the current year.

About ThermoGenesis

ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.